
Medtronic PLC Stock Underperforms Monday When Compared To Competitors

I'm PortAI, I can summarize articles.
Medtronic PLC's stock fell 1.30% to $98.57 on Monday, underperforming compared to competitors like Johnson & Johnson, Danaher Corp., and Abbott Laboratories, which saw gains. The stock is 7.30% below its 52-week high. Trading volume was higher than the 50-day average. The S&P 500 and Dow Jones also fell slightly.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

